Company page

Ascentage Pharma Group International

Ascentage Pharma Group International, traded under the ticker 6855 on the Hong Kong Stock Exchange, focuses on developing innovative therapies for cancer and age-related diseases. The company has a market capitalization of approximately HKD 1.55 billion. Ascentage aims to address unmet medical needs through its research and development efforts.

profile6855:HKEXAI content: aiUpdated June 24, 2026/company/ascentage-pharma-grp-international/c-r2r0kztp
Ascentage Pharma Group International logo
Ticker
6855:HKEX
Asset type
Stock
Market cap
$1.55B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
HKEX
Currency
HKD